{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:05:32Z","timestamp":1760385932185,"version":"3.33.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.nrl.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T12:54:03Z","timestamp":1665579243000},"page":"66-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Manifestaciones neurol\u00f3gicas asociadas a la vacuna contra COVID-19"],"prefix":"10.1016","volume":"40","author":[{"given":"R.","family":"Alonso Castillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Mart\u00ednez Castrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2022.09.005_bib0495","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10072-021-05662-9","article-title":"Spectrum of neurological complications following COVID-19 vaccination","volume":"43","author":"Garg","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0500","doi-asserted-by":"crossref","first-page":"577765","DOI":"10.1016\/j.jneuroim.2021.577765","article-title":"A systematic review of cases of CNS demyelination following COVID-19 vaccination","volume":"362","author":"Ismail","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0505","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-021-10747-8","article-title":"Interpretation of vaccine associated neurological adverse events: A methodological and historical review","volume":"269","author":"Cauchi","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0510","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ane.13417","article-title":"The potential neurological effect of the COVID-19 vaccines: A review","volume":"144","author":"Lu","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrl.2022.09.005_bib0515","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/vaccines9091022","article-title":"Reporting of acute inflammatory neuropathies with covid-19 vaccines: Subgroup disproportionality analyses in vigibase","volume":"9","author":"Noseda","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.nrl.2022.09.005_bib0520","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.nrl.2022.09.005_bib0525","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2022.09.005_bib0530","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2022.09.005_bib0535","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2022.09.005_bib0540","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2022.09.005_bib0545","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Goepfert","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2022.09.005_bib0550","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clinimag.2021.08.021","article-title":"Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?","volume":"80","author":"Goulart Corr\u00eaa","year":"2021","journal-title":"Clin Imaging."},{"key":"10.1016\/j.nrl.2022.09.005_bib0555","first-page":"372","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.nrl.2022.09.005_bib0560","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1111\/ene.15029","article-title":"Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: An analysis of cases notified to the European Medicines Agency","volume":"28","author":"Krzywicka","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0565","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ene.15113","article-title":"Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-2 vaccination","volume":"29","author":"Munckhof","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0570","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijid.2021.08.071","article-title":"Facial nerve palsy following the administration of COVID-19 mRNA vaccines: Analysis of a self-reporting database","volume":"111","author":"Sato","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.nrl.2022.09.005_bib0575","doi-asserted-by":"crossref","first-page":"108786","DOI":"10.1016\/j.clim.2021.108786","article-title":"Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study","volume":"229","author":"Garc\u00eda-Grimshaw","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0580","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.vaccine.2021.10.058","article-title":"Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study","volume":"39","author":"Garc\u00eda-Grimshaw","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.nrl.2022.09.005_bib0585","doi-asserted-by":"crossref","first-page":"108818","DOI":"10.1016\/j.clim.2021.108818","article-title":"Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine","volume":"230","author":"Garc\u00eda-Grimshaw","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0590","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2021.06.001","article-title":"Cerebral Venous Sinus Thrombosis in the U.S. Population After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19","volume":"78","author":"Bikdeli","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0595","doi-asserted-by":"crossref","first-page":"120030","DOI":"10.1016\/j.jns.2021.120030","article-title":"Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines","volume":"430","author":"Koh","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0600","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(21)01608-1","article-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK: Multicentre cohort study","volume":"398","author":"Perry","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2022.09.005_bib0605","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.26172","article-title":"COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany","volume":"90","author":"Schulz","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0610","article-title":"COVID-19: Post-vaccine Smell Taste Disorders: Report of 6 Cases Ear","author":"Lechien","year":"2021","journal-title":"Nose Throat J"},{"key":"10.1016\/j.nrl.2022.09.005_bib0615","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.dsx.2021.05.003","article-title":"Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence?","volume":"15","author":"Ghosh","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.nrl.2022.09.005_bib0620","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1212\/WNL.0000000000012703","article-title":"Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons from the Past to Inform the Present","volume":"97","author":"Thakur","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2022.09.005_bib0625","doi-asserted-by":"crossref","first-page":"117607","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; A systematic review","volume":"428","author":"Sharifian-Dorche","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0630","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbi.2021.04.006","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - A report of two UK cases","volume":"95","author":"Mehta","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nrl.2022.09.005_bib0635","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ene.15147","article-title":"Neurological autoimmune diseases following vaccinations against SARS-CoV-2: A case series","volume":"29","author":"Kaulen","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0640","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.26339","article-title":"Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System","volume":"91","author":"Frontera","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0645","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/qjmed\/hcab185","article-title":"COVID-19 vaccine-associated acute cerebral venous thrombosis pulmonary artery embolism","volume":"114","author":"Wang","year":"2021","journal-title":"QJM"},{"key":"10.1016\/j.nrl.2022.09.005_bib0650","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ana.26182","article-title":"Postvaccinal Encephalitis after ChAdOx1 nCov-19","volume":"90","author":"Zuhorn","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0655","first-page":"1","article-title":"Optic neuritis after COVID-19 vaccine application","volume":"00","author":"Garc\u00eda-Estrada","year":"2021","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0660","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12883-021-02427-x","article-title":"Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: A case report","volume":"21","author":"Tan","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0665","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s10072-021-05427-4","article-title":"Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19","volume":"42","author":"Chen","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0670","first-page":"1","article-title":"Guillain\u2013Barr\u00e9 syndrome after coronavirus disease 2019 vaccine: A temporal association","volume":"00","author":"da Silva","year":"2021","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0675","doi-asserted-by":"crossref","first-page":"e04756","DOI":"10.1002\/ccr3.4756","article-title":"COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect","volume":"9","author":"Matarneh","year":"2021","journal-title":"Clin Case Reports"},{"key":"10.1016\/j.nrl.2022.09.005_bib0680","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12883-021-02489-x","article-title":"Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination","volume":"21","author":"Nishiguchi","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0685","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jemermed.2021.07.062","article-title":"Guillain-Barr\u00e9 Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report","volume":"61","author":"Rossetti","year":"2021","journal-title":"J Emerg Med"},{"key":"10.1016\/j.nrl.2022.09.005_bib0690","doi-asserted-by":"crossref","first-page":"183","DOI":"10.14712\/18059694.2021.31","article-title":"Guillan-Barr\u00e9 Syndrome after First Vaccination Dose against COVID-19: Case Report","volume":"64","author":"\u010cen\u0161\u010d\u00e1k","year":"2021","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.nrl.2022.09.005_bib0695","doi-asserted-by":"crossref","first-page":"e246701","DOI":"10.1136\/bcr-2021-246701","article-title":"Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination","volume":"14","author":"Dang","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.nrl.2022.09.005_bib0700","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ana.26218","article-title":"Guillain-Barr\u00e9 Syndrome in an Australian State Using Both mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines","volume":"90","author":"Osowicki","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0705","doi-asserted-by":"crossref","first-page":"577691","DOI":"10.1016\/j.jneuroim.2021.577691","article-title":"Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature","volume":"359","author":"Min","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0985","first-page":"E357","article-title":"Cerebral venous thrombosis post BNT162b2 SARS-CoV-2 vaccination: mRNA. black swan A","volume":"96","author":"Fan","year":"2021","journal-title":"Am Event J Hematol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0715","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s00415-021-10599-2","article-title":"Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein t","volume":"268","author":"Graf","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0720","doi-asserted-by":"crossref","first-page":"e001095","DOI":"10.1136\/svn-2021-001095","article-title":"Cerebral venous sinus thrombosis after 19 vaccination with a misleading first cerebral MRI scan","volume":"6","author":"Ikenberg","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0725","doi-asserted-by":"crossref","first-page":"106072","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106072","article-title":"Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke","volume":"30","author":"Kenda","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2022.09.005_bib0730","doi-asserted-by":"crossref","first-page":"408","DOI":"10.25259\/SNI_689_2021","article-title":"A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management","volume":"12","author":"Kotal","year":"2021","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.nrl.2022.09.005_bib0735","doi-asserted-by":"crossref","first-page":"e246455","DOI":"10.1136\/bcr-2021-246455","article-title":"Cerebral venous sinus thrombosis after ChAdOx1 vaccination: The first case of definite thrombosis with thrombocytopenia syndrome from India","volume":"14","author":"Maramattom","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.nrl.2022.09.005_bib0740","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2022.09.005_bib0745","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/bloodadvances.2021004904","article-title":"A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2","volume":"5","author":"Sorensen","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.nrl.2022.09.005_bib0750","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.nrl.2022.09.005_bib0755","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10072-021-05714-0","article-title":"Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination","volume":"43","author":"Yagi","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0760","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2022.09.005_bib0765","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/jth.15347","article-title":"Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID- 19 vaccine","volume":"19","author":"Blauenfeldt","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nrl.2022.09.005_bib0770","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/ane.13505","article-title":"Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report","volume":"144","author":"M\u00e9lo","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrl.2022.09.005_bib0775","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.721502","article-title":"Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report","volume":"12","author":"Maniscalco","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0780","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1080\/21645515.2021.1971920","article-title":"demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report","volume":"17","author":"Mirmosayyeb","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.nrl.2022.09.005_bib0785","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2169\/internalmedicine.8747-21","article-title":"A Case of Refractory Longitudinally Extensive Transverse Myelitis after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in a Japanese Man","volume":"61","author":"Miyaue","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.nrl.2022.09.005_bib0790","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s13760-021-01699-x","article-title":"Acute disseminated encephalomyelitis - like presentation after an inactivated coronavirus vaccine","volume":"121","author":"Ozgen","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.nrl.2022.09.005_bib0795","doi-asserted-by":"crossref","first-page":"577606","DOI":"10.1016\/j.jneuroim.2021.577606","article-title":"A case of longitudinally extensive transverse myelitis following vaccination against Covid-19","volume":"358","author":"Pagenkopf","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0800","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12024-021-00440-7","article-title":"Acute disseminated encephalomyelitis (ADEM) following recent Oxford\/AstraZeneca COVID-19 vaccination","volume":"1","author":"Permezel","year":"2022","journal-title":"Forensic Sci Med Pathol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0805","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.radcr.2021.10.053","article-title":"Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine","volume":"17","author":"Sepahvand","year":"2022","journal-title":"Radiol Case Reports"},{"key":"10.1016\/j.nrl.2022.09.005_bib0810","doi-asserted-by":"crossref","first-page":"100381","DOI":"10.1016\/j.ensci.2021.100381","article-title":"An 88-year-old woman with acute disseminated encephalomyelitis following messenger ribonucleic acid-based COVID-19 vaccination","volume":"25","author":"Shimizu","year":"2021","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0815","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/qjmed\/hcab227","article-title":"Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA coronavirus disease-19 vaccine","volume":"114","author":"Takenaka","year":"2021","journal-title":"QJM"},{"key":"10.1016\/j.nrl.2022.09.005_bib0820","doi-asserted-by":"crossref","first-page":"577785","DOI":"10.1016\/j.jneuroim.2021.577785","article-title":"New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure","volume":"362","author":"Toljan","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0825","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18071\/isz.74.0273","article-title":"Acute transverse myelitis after inactivated COVID-19 vaccine","volume":"57","author":"\u015eim\u015fek Erdem","year":"2021","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.nrl.2022.09.005_bib0830","doi-asserted-by":"crossref","first-page":"577686","DOI":"10.1016\/j.jneuroim.2021.577686","article-title":"Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?","volume":"359","author":"Vegezzi","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0835","doi-asserted-by":"crossref","first-page":"106839","DOI":"10.1016\/j.clineuro.2021.106839","article-title":"Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination","volume":"208","author":"Vogrig","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nrl.2022.09.005_bib0840","first-page":"e17961","article-title":"Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine","volume":"13","author":"Fujikawa","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.nrl.2022.09.005_bib0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.nrl.2022.01.003","article-title":"\u201cWine Glass\u201d sign following COVID-19 vaccination in a previously healthy adult","author":"Ghosh","year":"2022","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/j.nrl.2022.09.005_bib0850","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00415-021-10648-w","article-title":"First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine","volume":"269","author":"Havla","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0855","first-page":"10101017","article-title":"Acute Transverse Myelitis after COVID-19 Vaccination","volume":"57","author":"Hsiao","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.nrl.2022.09.005_bib0860","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/acn3.51447","article-title":"Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2","volume":"8","author":"Kania","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0865","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","article-title":"COVID-19 mRNA vaccination leading to CNS inflammation: A case series","volume":"269","author":"Khayat-Khoei","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0870","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/qjmed\/hcab069","article-title":"COVID-19 vaccination-associated myelitis","volume":"114","author":"Malhotra","year":"2021","journal-title":"QJM"},{"key":"10.1016\/j.nrl.2022.09.005_bib0875","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12883-021-02517-w","article-title":"A case report of ChAdOx1 nCoV-19 vaccine-associated encephalitis","volume":"21","author":"Takata","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0880","doi-asserted-by":"crossref","first-page":"e243173","DOI":"10.1136\/bcr-2021-243173","article-title":"Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine","volume":"14","author":"Torrealba-Acosta","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.nrl.2022.09.005_bib0885","doi-asserted-by":"crossref","first-page":"100406","DOI":"10.1016\/j.bbih.2021.100406","article-title":"Aseptic meningitis after BNT-162b2 COVID-19 vaccination","volume":"19","author":"Chan","year":"2022","journal-title":"Brain, Behav Immun-Heal"},{"key":"10.1016\/j.nrl.2022.09.005_bib0890","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1007\/s10072-021-05543-1","article-title":"Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine","volume":"42","author":"Saito","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0895","first-page":"e18291","article-title":"Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 Vaccine","volume":"13","author":"Dalwadi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.nrl.2022.09.005_bib0900","doi-asserted-by":"crossref","first-page":"e244527","DOI":"10.1136\/bcr-2021-244527","article-title":"Guillain-Barr\u00e9 syndrome presenting with facial diplegia following COVID-19 vaccination in two patients","volume":"14","author":"Kanabar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.nrl.2022.09.005_bib0905","doi-asserted-by":"crossref","first-page":"e244125","DOI":"10.1136\/bcr-2021-244125","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 vaccination","volume":"14","author":"McKean","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.nrl.2022.09.005_bib0910","doi-asserted-by":"crossref","first-page":"577719","DOI":"10.1016\/j.jneuroim.2021.577719","article-title":"AstraZeneca COVID-19 vaccine and Guillain- Barr\u00e9 Syndrome in Tasmania: A causal link?","volume":"360","author":"Oo","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nrl.2022.09.005_bib0915","first-page":"1","article-title":"Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine","volume":"14","author":"Patel","year":"2021","journal-title":"ChAdOx1. BMJ Case Rep"},{"key":"10.1016\/j.nrl.2022.09.005_bib0920","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/20009666.2021.1954284","article-title":"A case of Guillain\u2013Barre syndrome following Pfizer COVID-19 vaccine","volume":"11","author":"Rao","year":"2021","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.nrl.2022.09.005_bib0925","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1007\/s10072-021-05523-5","article-title":"Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine","volume":"42","author":"Trimboli","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0930","doi-asserted-by":"crossref","first-page":"286","DOI":"10.18071\/isz.74.0286","article-title":"A variant of Guillain-Barre syndrome after sars-cov-2 vaccination: Amsan","volume":"74","author":"Tutar","year":"2021","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.nrl.2022.09.005_bib0935","first-page":"4747","article-title":"A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine","volume":"19","author":"Alessandro","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinimag.2021.10.010","article-title":"Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report","volume":"82","author":"Cellina","year":"2022","journal-title":"Clin Imaging"},{"key":"10.1016\/j.nrl.2022.09.005_bib0945","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ane.13548","article-title":"Multiple cranial nerve palsies following COVID. Case report","volume":"145","author":"Manea","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrl.2022.09.005_bib0950","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1007\/s10072-021-05496-5","article-title":"Bell's palsy following COVID-19 vaccination with high CSF antibody response","volume":"42","author":"Obermann","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03000605211056783","article-title":"Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: A case report","volume":"49","author":"Kim","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.nrl.2022.09.005_bib0960","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1002\/mus.27255","article-title":"Parsonage Turner syndrome after COVID-19 vaccination","volume":"64","author":"Mahajan","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nrl.2022.09.005_bib0965","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s13256-021-03176-8","article-title":"Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: A case report and review of the literature","volume":"15","author":"Vitturi","year":"2021","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.nrl.2022.09.005_bib0970","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1007\/s10072-021-05504-8","article-title":"Functional neurological disorder after COVID-19 vaccination","volume":"42","author":"Ercoli","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2022.09.005_bib0975","first-page":"e19433","article-title":"Oral Herpes Zoster Infection Following COVID-19 Vaccination?: A Report of Five Cases Case Presentation","volume":"13","author":"Fukuoka","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.nrl.2022.09.005_bib0980","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ca.23790","article-title":"A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination","volume":"35","author":"Iwanaga","year":"2022","journal-title":"Clin Anat"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485322001876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485322001876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T19:26:25Z","timestamp":1736969185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485322001876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0213485322001876"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2022.09.005","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestaciones neurol\u00f3gicas asociadas a la vacuna contra COVID-19","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}